Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Growth Hormone and Intrahepatic Lipid Content in Patients With Nonalcoholic Fatty Liver Disease

NCT02217345 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT02217345
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02217345 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Growth Hormone and Intrahepatic Lipid Content in Patients With Nonalcoholic Fatty Liver Disease
Lead sponsor
Massachusetts General Hospital
Phase
Phase 2
Overall status
Completed
Start date
June 2, 2017
Completion date
September 13, 2021
Enrollment
131 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

nonalcoholic fatty liver disease (nafld)